José de Jesús Flores-Sierra, Magaly Del Rosario Muciño-Arellano, Gloria Del Carmen Romo-Morales, Jaime Eduardo Sánchez-Palafox, Viridiana Abigail Correa-Navarro, Dannia Colín-Castelán, Victoriano Pérez-Vázquez, Rubén Rangel-Salazar, Rafael Rivera-Bustamante, Carmen de la Rocha, Dalia Rodríguez-Ríos, Diana Lilia Trejo-Saavedra, Jorge Molina-Torres, Enrique Ramírez-Chávez, Nancy Shyrley García-Rojas, Robert Winkler, Gertrud Lund, Silvio Zaina
Increasing evidence hints that DNA hypermethylation may mediate the pathogenic response to cardiovascular risk factors. Here, we tested a corollary of that hypothesis, i.e., that the DNA methyltransferase inhibitor decitabine (Dec) ameliorates the metabolic profile of mice fed a moderately high-animal fat and protein diet (HAFPD), a proxy of cardiovascular risk-associated Western-type diet. HAFPD-fed mice were exposed to Dec or vehicle for eight weeks (8W set, 4-32/group). To assess any memory of past exposure to Dec, we surveyed a second mice set treated as 8W but HAFPD-fed for further eight weeks without any Dec (16W set, 4-20/group)...
June 26, 2024: Journal of Lipid Research